Literature DB >> 8304361

Osteoporosis and bone morbidity in cardiac transplant recipients.

A H Lee1, R L Mull, G F Keenan, P E Callegari, M K Dalinka, H J Eisen, D M Mancini, V J DiSesa, M F Attie.   

Abstract

PURPOSE: To evaluate the incidence and etiology of osteopenia and pathologic fractures in cardiac transplant recipients. PATIENTS: Thirty-one adult male cardiac transplant recipients and 14 adult men with congestive heart failure (CHF) awaiting cardiac transplantation.
METHODS: Assessment of indices of bone and mineral metabolism and of bone mineral density (BMD) by dual-energy x-ray absorptiometry.
RESULTS: BMD in the proximal femur was below normal in both groups compared to that in age-matched control subjects, whereas BMD in the lumbar spine was normal. There was no significant difference in BMD at any site between the two groups. No clinical parameter predicted BMD. In all patients, laboratory indices of bone mineral metabolism, except parathyroid hormone (PTH) levels, were normal and not statistically different between the two groups. CHF patients had a trend toward elevations of PTH, 1,25-dihydroxyvitamin D, and urinary calcium excretion compared to transplant patients. Eight of 31 transplant patients and 2 of 14 CHF patients had vertebral compression fractures (c2 = 11.8, p < 0.0006). Transplant recipients with fractures had twice as many rejection episodes as did transplant patients without fractures, but did not differ in cumulative dose of steroids. Two patients developed avascular necrosis of the femoral head following transplantation.
CONCLUSIONS: Cardiac transplant recipients and patients with CHF awaiting transplantation had decreased hip BMD, but normal spine BMD. Although immunosuppressive therapy did not appear to influence bone mass, loop diuretics prior to transplantation may have stimulated a mild secondary increase in PTH that could have differentially caused loss of bone density at the hip in both groups. Pulse corticosteroids used in treating rejection may have contributed to the increased incidence of vertebral fractures in transplant patients. These data suggest that severe CHF with its associated diuretic use and decreased activity are primary contributors to osteopenia in these patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8304361     DOI: 10.1016/0002-9343(94)90113-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  25 in total

1.  Congestive heart failure: where homeostasis begets dyshomeostasis.

Authors:  German Kamalov; Syamal K Bhattacharya; Karl T Weber
Journal:  J Cardiovasc Pharmacol       Date:  2010-09       Impact factor: 3.105

2.  Outcome of muscle and bone development in congenital heart disease.

Authors:  Cordelia Witzel; Narayanswami Sreeram; Silke Coburger; Sabine Schickendantz; Konrad Brockmeier; Eckhard Schoenau
Journal:  Eur J Pediatr       Date:  2005-12-01       Impact factor: 3.183

Review 3.  Micronutrients and their supplementation in chronic cardiac failure. An update beyond theoretical perspectives.

Authors:  Klaus K Witte; Andrew L Clark
Journal:  Heart Fail Rev       Date:  2006-03       Impact factor: 4.214

Review 4.  Disturbances in calcium metabolism and cardiomyocyte necrosis: the role of calcitropic hormones.

Authors:  Jawwad Yusuf; M Usman Khan; Yaser Cheema; Syamal K Bhattacharya; Karl T Weber
Journal:  Prog Cardiovasc Dis       Date:  2012 Jul-Aug       Impact factor: 8.194

5.  Femoral bone mineral density in patients with heart failure.

Authors:  A M Kenny; R Boxer; S Walsh; W D Hager; L G Raisz
Journal:  Osteoporos Int       Date:  2006-06-13       Impact factor: 4.507

6.  Intracellular calcium overloading and oxidative stress in cardiomyocyte necrosis via a mitochondriocentric signal-transducer-effector pathway.

Authors:  Mazen Shaheen; Yaser Cheema; Atta U Shahbaz; Syamal K Bhattacharya; Karl T Weber
Journal:  Exp Clin Cardiol       Date:  2011

Review 7.  Congestive heart failure is a systemic illness: a role for minerals and micronutrients.

Authors:  Shadwan Alsafwah; Stephen P Laguardia; Maximiliano Arroyo; Brian K Dockery; Syamal K Bhattacharya; Robert A Ahokas; Kevin P Newman
Journal:  Clin Med Res       Date:  2007-12

8.  Dynamics of bone turnover markers in patients with heart failure and following haemodynamic improvement through ventricular assist device implantation.

Authors:  Christina Wu; Tomoko S Kato; Katherine Pronschinske; Sylvia Qiu; Yoshifumi Naka; Hiroo Takayama; Ulrike Schulze-Späte; Serge Cremers; Elizabeth Shane; Donna Mancini; P Christian Schulze
Journal:  Eur J Heart Fail       Date:  2012-09-18       Impact factor: 15.534

Review 9.  [Obesity and cardiac cachexia in chronic heart failure].

Authors:  M Clauser; J Altenberger
Journal:  Herz       Date:  2013-09       Impact factor: 1.443

Review 10.  Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium.

Authors:  Karl T Weber; William B Weglicki; Robert U Simpson
Journal:  Cardiovasc Res       Date:  2008-10-03       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.